Login
Login
切换导航
Home
Articles
Journals
Books
News
About
Services
Submit
Home
Journal
Articles
Journals A-Z
Browse Subjects
Biomedical & Life Sci.
Business & Economics
Chemistry & Materials Sci.
Computer Sci. & Commun.
Earth & Environmental Sci.
Engineering
Medicine & Healthcare
Physics & Mathematics
Social Sci. & Humanities
Browse Subjects
Biomedical & Life Sciences
Business & Economics
Chemistry & Materials Science
Computer Science & Communications
Earth & Environmental Sciences
Engineering
Medicine & Healthcare
Physics & Mathematics
Social Sciences & Humanities
Publish with us
Paper Submission
Information for Authors
Peer-Review Resources
Open Special Issues
Open Access Statement
Frequently Asked Questions
Publish with us
Paper Submission
Information for Authors
Peer-Review Resources
Open Special Issues
Open Access Statement
Frequently Asked Questions
Follow SCIRP
Contact us
+1 323-425-8868
customer@scirp.org
+86 18163351462(WhatsApp)
1655362766
Paper Publishing WeChat
Complete Matching
Editorial Board
Show/Hide Options
Show/Hide Options
All
Title
Abstract
Keywords
DOI
Author
Journal
Affiliation
ISSN
Subject
Dapagliflozin and Spironolactone Improved Clinical Symptoms and CV Outcomes in Patient with HF Preserved Ejection Fraction (HFpEF) in Hard-to-Reach Rural African Population: A Case Series
(Articles)
Dominick Mkombozi Raphael
,
Abdu Hussein Mogella
,
Elias Edrick Mtalemwa
,
Beatrice Kabuka
Case Reports in Clinical Medicine
Vol.11 No.11
,November 9, 2022
DOI:
10.4236/crcm.2022.1111064
102
Downloads
1,566
Views
Citations
Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors in Type 2 Diabetes: A Literature Review of Approved Products
(Review)
Lucio R. Volino
,
Eva Y. Pan
,
Rupal Patel Mansukhani
Pharmacology & Pharmacy
Vol.5 No.11
,October 27, 2014
DOI:
10.4236/pp.2014.511114
4,665
Downloads
7,142
Views
Citations
Meta-Analysis on Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus
(Articles)
Lili She
,
Hongyan Wu
Yangtze Medicine
Vol.2 No.3
,August 30, 2018
DOI:
10.4236/ym.2018.23014
1,011
Downloads
2,130
Views
Citations
The Safety and Efficacy of Combination Therapy of Dapagliflozin and Metformin in Patient with Type 2 Diabetes Mellitus: A Review Study
(Articles)
Saif K. Alkhanferi
,
Khadeejah H. Alhuraiz
,
Hussein S. Alyami
,
Sultan L. Alenazi
,
Mohammed F. Aldhaban
,
Naif Alrowedann
,
Yazeed Y. Albedaiwi
,
Nawal Alnazawi
,
Abrar Bokhamseen
,
Fatimah A. Talaqof
Journal of Diabetes Mellitus
Vol.12 No.4
,November 25, 2022
DOI:
10.4236/jdm.2022.124022
262
Downloads
1,961
Views
Citations
Cost Utility Analysis of Dapagliflozin in Egyptian Patients with CKD from the Payer Perspective
(Articles)
Gamal Saadi
,
Magdy Elsharkawy
,
Gamal Fathy El-Naggar
,
Ahmed F. Elkeraie
,
Emad R. Issak
Open Journal of Nephrology
Vol.13 No.4
,December 18, 2023
DOI:
10.4236/ojneph.2023.134040
109
Downloads
324
Views
Citations
Saudi Consensus on the Usage of Sodium-Glucose Cotransporter-2 Inhibitors on the Management of Chronic Kidney Diseases
(Articles)
Abdulrahman Alsheikh
,
Ahmed Aljedai
,
Hajer Almudaiheem
,
Salwa Alaidarous
,
Ali Alshehri
,
Hussein Elbadawi
,
Saeed Alghamdi
,
Faisal Aljehani
,
Sami Alobaidi
,
Talal A. Altuwaijri
,
Khalid Almatham
,
David Strain
,
Marc Evans
,
Emad R. Issak
,
Saud Alsifri
International Journal of Clinical Medicine
Vol.14 No.12
,December 25, 2023
DOI:
10.4236/ijcm.2023.1412045
89
Downloads
397
Views
Citations
Follow SCIRP
Contact us
+1 323-425-8868
customer@scirp.org
+86 18163351462(WhatsApp)
1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Home
Journals A-Z
Subject
Books
Sitemap
Contact Us
About SCIRP
Publication Fees
For Authors
Peer-Review Issues
Special Issues
News
Service
Manuscript Tracking System
Subscription
Translation & Proofreading
FAQ
Volume & Issue
Policies
Open Access
Publication Ethics
Preservation
Retraction
Privacy Policy
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top